Survival trends in young patients with Waldenstrom macroglobulinemia (WM).

被引：0
|
作者：
Vallumsetla, Nishanth
Paludo, Jonas
Gertz, Morie
Ansell, Stephen Maxted
Go, Ronald S.
Rajkumar, Vincent
Kyle, Robert A.
Buadi, Francis
Dispenzieri, Angela
Lacy, Martha
Dingli, David
Hayman, Suzanne R.
Leung, Nelson
Kumar, Shaji
Kapoor, Prashant
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8596
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A Phase 2 Trial Investigating Epcoritamab in Patients with Previously Treated Waldenstrom Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (WM-NET3)
    von Keudell, Gottfried
    Logan, Emma K.
    Redd, Robert A.
    Sarosiek, Shayna R.
    Branagan, Andrew R.
    Anderson Jr, Larry D.
    Dittus, Christopher
    Treon, Steven P.
    Castillo, Jorge J.
    BLOOD, 2024, 144 : 6294 - 6295
  • [42] The Natural History of Asymptomatic (Smoldering) Waldenstrom Macroglobulinemia (WM): Factors Predicting Progression to Symptomatic WM and Transformation
    Kaldas, David
    Thapa, Shrin
    Modukuri, Shrikar
    Shain, Ken
    Blue, Brandon
    Alsina, Melissa
    Baz, Rachid
    Grajales-Cruz, Ariel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S506 - S506
  • [43] Targeting NF-kB by perifosine, bortezomib and rituximab in Waldenstrom macroglobulinemia (WM)
    Leleu, Xavier
    Jerome, Eeckhoute
    Jia, Xiaoying
    Moreau, Anne-Sophie
    Roccaro, Aldo M.
    Farag, Mena
    Sacco, Antonio
    Hatjiharissi, Evdoxia
    Ngo, Hai T.
    Runnels, Judith
    Azab, Abdelkareem
    Azab, Feda
    Hunter, Zachary
    Sportelli, Peter
    Treon, Steven P.
    Hideshima, Teru
    Anderson, Kenneth C.
    Ghobrial, Irene M.
    BLOOD, 2007, 110 (11) : 741A - 741A
  • [44] Comparative Effectiveness of Rituximab-Based Immunochemotherapy in Waldenstrom's Macroglobulinemia (WM)
    Olszewski, Adam J.
    Treon, Steven P.
    Castillo, Jorge J.
    BLOOD, 2016, 128 (22)
  • [45] Primary treatment of Waldenstrom's macroglobulinemia (WM) with dexamethasone, rituximab and cyclophosphamide.
    Dimopoulos, Meletios A.
    Anagnostopoulos, Athanasios
    Kyrtsonis, Marie Christine
    Tsatalas, Constantinos
    Kokkini, Garyfallia
    Repoussis, Panagiotis
    Zomas, Athanasios
    Symeonidis, Argiris
    Michali, Evridiki
    Anagnostopoulos, Nikolaos
    Terpos, Evangelos
    Economopoulos, Theophanis
    Pangalis, Gerasimos
    BLOOD, 2006, 108 (11) : 42A - 42A
  • [46] Heterogeneity of Histological Transformation Events in Waldenstrom's Macroglobulinemia (WM) and Related Disorders
    Owen, R. G.
    Bynoe, A. G.
    Varghese, A.
    de Tute, R. M.
    Rawstron, A. C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (01): : 176 - 179
  • [47] Primary treatment of Waldenstrom's Macroglobulinemia (WM) with dexamethasone, rituximab and cyclophosphamide.
    Dimopoulos, MA
    Kyrtsonis, MC
    Tsatalas, C
    Kokkini, G
    Repoussis, P
    Zomas, A
    Symeonidis, A
    Michali, E
    Anagnostopoulos, A
    Anagnostopoulos, N
    Economopoulos, T
    Pangalis, G
    BLOOD, 2004, 104 (11) : 215A - 215A
  • [48] Exploration of rare variants from exome sequencing in families with Waldenstrom macroglobulinemia (WM)
    McMaster, Mary L.
    Goldin, Lynn R.
    Rotunno, Melissa
    He, Ji
    Burdette, Laurie
    Hutchinson, Amy
    Boland, Joseph
    Yeager, Meredith
    Tucker, Margaret A.
    Chanock, Stephen J.
    Caporaso, Neil E.
    CANCER RESEARCH, 2014, 74 (19)
  • [49] The unfolded protein response is a determinant of disease actvity in Waldenstrom's Macroglobulinemia (WM)
    Leleu, X
    Xu, L
    Santos, DD
    Ho, AW
    Hunter, ZR
    O'Connor, K
    Manning, RJ
    Tournilhac, O
    Chemaly, M
    Branagan, AR
    Patterson, CJ
    Anderson, KC
    Treon, S
    BLOOD, 2005, 106 (11) : 292A - 292A
  • [50] CHOP plus rituximab (CHOP-R) in Waldenstrom's macroglobulinemia (WM).
    Hunter, Z
    Branagan, A
    Treon, S
    BLOOD, 2004, 104 (11) : 314B - 314B
12345